Related Posts

Dr JF Prost joins Mabqi leadership team as new Medical Director
Mabqi is thrilled to welcome Jean-François Prost, MD, as Acting Medical Director. With over 30 years of top management experience in... Lire la suite

New scientific paper published in mAbs, 2024
Mabqi is proud to co-author the scientific article « Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple... Lire la suite

Mabqi will be attending BIO EUROPE 2024
Mabqi will be attending the Festival of Biologics from October 15th to October 17th 2024 in Basel, Switzerland. Lire la suite

Mabqi will be attending the FOB 2024
Mabqi will be attending the Festival of Biologics from October 15th to October 17th 2024 in Basel, Switzerland. Lire la suite

Mabqi will be attending at the Convention BIO US 2024
Mabqi will be attending the Convention BIO US innovation organization from June 3rd to June 6th at #SanDiego, #California... Lire la suite

Mabqi contributed to the article « Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis » published in the journal Nature Communications on August 31, 2023.
Mabqi is proud to have contributed to the article "Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic... Lire la suite